Comments Off on Prometheus, Jeff Bezos’ AI startup, is now worth $41 billion
Comments Off on UCB to Acquire Candid Therapeutics
Comments Off on Building Bold Companies
Comments Off on Alumis soars as TYK2 drug hits mark in psoriasis trials
Comments Off on Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell
Comments Off on How AI Will Transform Drug Discovery with Foresite Labs CEO Vik Bajaj
Comments Off on Q&A: Project Stargate and the viability of AI cancer vaccines
Comments Off on AI-based predictive biology coming soon, Foresite’s Bajaj says
Comments Off on Grail and Verily Alum on Billion Dollar Startup Bringing AI to Drug Development: A Discussion with Vik Bajaj
Comments Off on The Nobel Prize in Chemistry
